Free weekly newsletter

Get the free weekly executive digest

The new leadership moves, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.

Weekly Digest

New leadership moves, summarized for you

Straight to Inbox

No login, no app to check — it comes to you

Leadership Trends

See who's moving and how much in your market

No credit card required Weekly executive digest

Igor Bluvstein Appointed Chief Financial Officer At Revium Rx

PUBLIC · RVRCJun 01, 2026•16 days ago

Position

Chief Financial Officer

Company

Revium Rx

Arie Gordashnikov

IsraelBiotechnologyHealth CareTherapeuticsPharmaceutical

Description

On May 27, 2026, REVIUM Rx announced the appointment of Mr. Igor Bluvstein as the Chief Financial Officer. This follows the resignation of Mr

Company Information

Company

Revium Rx

Location

Israel

About

Revium Rx (formerly Revium Recovery Inc., OTC: RVRC) is a pharmaceutical company that focuses on advanced therapeutics and drug delivery technologies for hard-to-treat diseases. With a renewed commitment to drug delivery innovation, Revium Rx is at the forefront of developing nanoparticle-based therapeutics.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence

Strategic

ML-powered predictions for Revium Rx's next move

Learn about Strategic plan

Executive Insights

Based on hiring data

New executive impact window

87% of new executives make significant technology decisions within first 100 days

Budget influence

C-level executives control 73% of technology spending decisions

Transformation catalyst

65% of new senior hires launch digital transformation initiatives

Vendor review timeline

New executives typically review existing vendors within 6 months